Sleep Strategies
-
Sleep in the ICU: Why closed eyes do not mean rest
Unconsciousness is not synonymous with sleep. Available evidence increasingly supports treating sleep as an essential component of ICU care rather than a secondary comfort measure.
-
The evaluation and management of OSA in medically hospitalized patients
These recommendations will hopefully prompt institutions to develop protocols for screening, diagnosing, and potentially offering PAP therapy to this patient population.
-
A ‘central’ issue in sleep medicine
An AASM task force recently published guidelines on central sleep apnea management, which includes recommendations on whether adaptive servo-ventilation is a safe option in these patients.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
-
Using consumer sleep trackers in clinical practice
Consumer sleep technologies are offering new ways to monitor sleep. Clinicians need to be prepared to discuss this data, clarify limitations, and interpret findings with patients.
-
OSA and the Alzheimer’s continuum
OSA is being increasingly recognized as a potential contributor to neurodegeneration, particularly in the preclinical stages of Alzheimer’s disease. As early intervention becomes a priority in Alzheimer’s prevention, sleep disorders are being investigated as modifiable risk factors.
-
Reexamining treatment for RLS: What do the new AASM guidelines teach us?
The key clinical takeaway from the new guidelines is that dopamine agonists are no longer first-line therapy for RLS, and gabapentinoids should be used as primary therapy for most patients.
-
Should napping be recommended as a health behavior?
The quest for an effective, inexpensive, and manageable intervention for sleep loss often leads to the question: What about naps? Author Sara C. Mednick, PhD, lists the pros and cons.
-
OSA in pregnancy: Who to test, how to screen, and does treatment help?
The estimated prevalence of OSA in pregnancy ranges from 4% to 27% compared with 0.7% to 6.5% in nonpregnant, reproductive-age females, with an even higher prevalence in complicated pregnancies.1 The increased prevalence in pregnancy can be explained by physiologic changes impacting the upper airway such as increases in maternal blood volume and reductions in oncotic…
-
On 5 Ps: PSG, PM, PPG, PulseOx, and PAT
OSA is a very prevalent condition in the general population, but still many patients remain undiagnosed and untreated. Prolonged, untreated OSA is an independent risk factor for major cardiovascular morbidity and mortality. Therefore, timely diagnosis and treatment are required. Polysomnography (PSG) remains to this day the gold standard for diagnosing sleep apnea. A standard PSG…
